Revitope Oncology is a biotech company leveraging biological insights and protein engineering to develop a new class of cancer immunotherapies powered for precision.

Biotechnology

Revitope Oncology

The Cambridge office focuses on scientific leadership and innovation, driving research and development in biotechnology.

Cambridge

Revitope Oncology's headquarters in San Francisco, CA, United States

Mark Clement

Werner Meier

Louis Lange

Andrew Allen

Carsten Reinhardt

Peter Joost

Raj Mehta

The Directors Team at Revitope Oncology comprises senior leaders responsible for steering the company's strategic direction, overseeing research and development initiatives, and ensuring alignment with corporate goals. This team collaborates closely to drive innovation in cancer immunotherapies and fosters partnerships to advance the company's mission.

Directors Team

The Leadership Team at Revitope Oncology is responsible for setting the strategic direction and vision of the company, overseeing operations, and guiding the development of innovative cancer immunotherapies. This team integrates insights from scientific research and business strategy to ensure successful execution of projects, fostering collaboration among departments to drive advancements in precision medicine. Their collective expertise in leadership and biotechnology positions Revitope at the forefront of cancer treatment innovation.

Revitope Oncology

Org chart

Board & advisors

Teams

Directors Team

Leadership Team

Offices

Revitope Oncology

Org chart

Board & advisors

Teams

Directors Team

Leadership Team

Offices

Related companies